Location History:
- Old Westbury, NY (US) (2019 - 2020)
- San Francisco, CA (US) (2022)
Company Filing History:
Years Active: 2019-2022
Title: Innovations by Inventor Daniel De Roulet
Introduction
Daniel De Roulet, a distinguished inventor based in Old Westbury, NY, has made significant contributions to the field of medicine through his innovative work. With three patents to his name, De Roulet focuses primarily on developing treatments for neurodegenerative and mitochondrial diseases. He is affiliated with Mitokinin, Inc., a company that specializes in advancing scientific research into therapeutic solutions.
Latest Patents
De Roulet's most recent patents showcase his dedication to addressing critical health challenges. One patent is directed towards substituted purines and their pharmaceutically acceptable salts, aimed at treating and preventing neurodegenerative diseases, mitochondrial disease, fibrosis, and cardiomyopathy. The second patent focuses on similar compounds and their salts for the treatment and prevention of conditions such as Parkinson's disease and Leigh's disease. Both patents highlight the use of nitrogenous bases, including purines and pyrimidines, as essential components in these therapeutic strategies.
Career Highlights
Throughout his career, Daniel De Roulet has demonstrated a commitment to innovative research and development. Working at Mitokinin, Inc., he has contributed to advancing the company’s mission of addressing complex health issues. His work not only adds value to his organization but also pushes the boundaries of scientific knowledge in the field of neurodegeneration and mitochondrial health.
Collaborations
De Roulet collaborates closely with his coworker, Robert Joseph Devita, contributing to a dynamic research environment at Mitokinin, Inc. This partnership is instrumental in driving forward the research and development initiatives focused on groundbreaking treatments for debilitating diseases.
Conclusion
Daniel De Roulet exemplifies the spirit of innovation within the medical field. His patents reflect a deep understanding of neurodegenerative and mitochondrial diseases, demonstrating his commitment to improving patient outcomes through his work. As he continues to develop new therapeutic solutions, the essence of his contributions to medicine will undeniably resonate with future advancements.